✦ LIBER ✦

Southwest Oncology Group Phase II Study of Irinotecan in Patients with Advanced Transitional Cell Carcinoma of the Urothelium that Progressed After Platinum-Based Chemotherapy

✍ Scribed by Tomasz M. Beer; Bryan Goldman; Craig R. Nichols; Daniel P. Petrylak; Manoj Agarwal; Christopher W. Ryan; E. David Crawford

Book ID: 119935412
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 107 KB
Volume: 6
Category: Article
ISSN: 1558-7673
DOI: 10.3816/cgc.2008.n.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Trial of Piroxantrone in Adva

A Phase II Trial of Piroxantrone in Advanced Ovarian Carcinoma after Failure of Platinum-Based Chemotherapy: Southwest Oncology Group Study 8904

✍ Kathy S. Albain; P.Y. Liu; Alexander Hantel; Elizabeth A. Poplin; Robert V. O'To 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Results of the Southwest Oncology Group

Results of the Southwest Oncology Group phase II evaluation (study S0031) of ZD1839 for advanced transitional cell carcinoma of the urothelium

✍ Daniel P. Petrylak; Catherine M. Tangen; Peter J. Van Veldhuizen Jr; J. Wendall 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB

Weekly Paclitaxel and Gemcitabine in Adv

Weekly Paclitaxel and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium: A Phase II Hoosier Oncology Group Study

✍ Montie, James E. 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 44 KB

A phase II study of flavopiridol in pati

A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109

✍ Peter J. Van Veldhuizen; James R. Faulkner; Primo N. Lara; Paul H. Gumerlock; J. 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 217 KB

A phase II trial of interferon-α and 5-f

A phase II trial of interferon-α and 5-fluorouracil in patients with advanced renal cell carcinoma: A Southwest Oncology Group study

✍ Laurence Elias; Brent A. Blumenstein; Julie Kish; Robert C. Flanigan; James L. W 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 1 views

## BACKGROUND. Renal cell carcinoma is a common neoplasm that is often refractory to treatment. It is occasionally responsive to immunoniodulating agents including interferon-a, which enhances the effects of 5-fluorouracil upon cells. Combinations of these two drugs have been most frequently tested

Phase II clinical study of gemcitabine i

Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy

✍ Li Zhang; Yang Zhang; Pei-Yu Huang; Fei Xu; Pei-Jian Peng; Zhong-Zhen Guan 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 302 KB